American Heart Association – 2018 DECLARE – TIMI 58 Primary Results (Wiviott AHA 2018) Caffeine and Dyspnea with Ticagrelor in PEGASUS (Furtado AHA 2018) Ticagrelor for long-term secondary prevention in patients with prior MI and no history of coronary stenting in PEGASUS (Furtado AHA 2018) High-sensitivity Cardiac Troponin at Any Detectable Concentration Identifies Higher Risk of Major CV Events in Patients with Stable IHD in PEGASUS (Marston AHA 2018) Biomarkers for the Assessment of Stroke-Systemic Embolism and Bleeding Risk in Patients with AF in ENGAGE (Berg AHA 2018) Morphine-Clopidogrel Interaction & CV Outcomes in Pts with Non-STEMI ACS in EARLY (Furtado AHA 2018) Association of Genetic Risk Score with Risk of Recurrent Coronary Events in IMPROVE-IT (Ruff AHA 2018) Prognostic Value of Elevated Triglycerides in AS Disease in FOURIER (Marston AHA 2018) Plasma Omega-6 Fatty Acids & the Risk of CV Events in Patients After Acute ACS in MERLIN (Zelniker AHA 2018) Share this:TwitterFacebookLike this:Like Loading...